Moderna and Merck Announce Cancer Vaccine Breakthrough

Moderna and Merck have reported a significant breakthrough in cancer vaccines, particularly for melanoma, which could lead to a new wave of treatments. The market reaction to Moderna's melanoma results has been noted as contrary to expectations.